Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Suppression of tumorigenicity 13 pseudogene (Ensembl: ENSG00000258230) is a non-protein-coding segment of human DNA that closely resembles the functional ST13 gene but does not encode a protein product[4][6][16]. The parent gene, ST13, encodes a co-chaperone protein (Hsc70-interacting protein, HIP) that modulates heat shock protein activity and has been proposed, though not conclusively proven, as a tumor suppressor[1][7]. However, the pseudogene variant referenced here does not contribute directly to cellular biological functions or disease processes and is not a therapeutic target. There is no documented role for this specific pseudogene as a biomarker, drug target, or in disease pathology, and it is primarily of interest as a genomic annotation[4][6][16]. Note: If you are interested in the functional protein-coding gene *Suppression of tumorigenicity 13* (ST13/HIP), this is a different entity with potential—though as yet only limited—association with tumor suppression[1][7][13]. The pseudogene does not share those properties.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Suppression of tumorigenicity 13 pseudogene (ST13P).